Zacks Research Analysts Lower Earnings Estimates for CLB

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Core Laboratories in a research report issued to clients and investors on Friday, January 17th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings per share of $0.27 for the quarter, down from their prior forecast of $0.28. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.24 EPS and Q3 2026 earnings at $0.32 EPS.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.04. The company had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. Core Laboratories’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period last year, the firm posted $0.22 EPS.

A number of other equities analysts have also recently weighed in on the company. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup reduced their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, Core Laboratories currently has an average rating of “Hold” and an average price target of $17.00.

Core Laboratories Stock Up 3.3 %

Shares of CLB stock opened at $19.73 on Monday. The company has a current ratio of 2.48, a quick ratio of 1.79 and a debt-to-equity ratio of 0.55. Core Laboratories has a twelve month low of $13.82 and a twelve month high of $25.13. The stock has a 50 day moving average of $19.13 and a 200 day moving average of $19.56. The stock has a market cap of $926.51 million, a P/E ratio of 30.36, a P/E/G ratio of 0.98 and a beta of 2.39.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC boosted its stake in Core Laboratories by 2,688.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock worth $42,000 after buying an additional 2,339 shares during the period. Ridgewood Investments LLC boosted its position in shares of Core Laboratories by 4.6% during the 4th quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company’s stock worth $565,000 after purchasing an additional 1,428 shares during the period. Confluence Investment Management LLC increased its holdings in Core Laboratories by 0.4% in the 4th quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company’s stock valued at $2,360,000 after purchasing an additional 599 shares during the last quarter. JPMorgan Chase & Co. raised its position in Core Laboratories by 5.8% in the third quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company’s stock valued at $765,000 after purchasing an additional 2,267 shares during the period. Finally, Tidal Investments LLC lifted its stake in Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company’s stock worth $813,000 after purchasing an additional 716 shares in the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.04 annualized dividend and a yield of 0.20%. Core Laboratories’s payout ratio is 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.